142 related articles for article (PubMed ID: 20438574)
21. Electrostatic ratchet in the protective antigen channel promotes anthrax toxin translocation.
Wynia-Smith SL; Brown MJ; Chirichella G; Kemalyan G; Krantz BA
J Biol Chem; 2012 Dec; 287(52):43753-64. PubMed ID: 23115233
[TBL] [Abstract][Full Text] [Related]
22. Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design.
Karginov VA; Nestorovich EM; Moayeri M; Leppla SH; Bezrukov SM
Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15075-80. PubMed ID: 16214885
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of anthrax protective antigen outside and inside the cell.
Backer MV; Patel V; Jehning BT; Claffey KP; Karginov VA; Backer JM
Antimicrob Agents Chemother; 2007 Jan; 51(1):245-51. PubMed ID: 17074791
[TBL] [Abstract][Full Text] [Related]
24. Membrane insertion of anthrax protective antigen and cytoplasmic delivery of lethal factor occur at different stages of the endocytic pathway.
Abrami L; Lindsay M; Parton RG; Leppla SH; van der Goot FG
J Cell Biol; 2004 Aug; 166(5):645-51. PubMed ID: 15337774
[TBL] [Abstract][Full Text] [Related]
25. Anthrax-toxin-mediated delivery of a 19 kDa antigen of Mycobacterium tuberculosis into the cytosol of mammalian cells.
Mehra V; Khanna H; Chandra R; Singh Y
Biotechnol Appl Biochem; 2001 Apr; 33(2):71-4. PubMed ID: 11277858
[TBL] [Abstract][Full Text] [Related]
26. Translocation of Non-Canonical Polypeptides into Cells Using Protective Antigen.
Rabideau AE; Liao X; Akçay G; Pentelute BL
Sci Rep; 2015 Jul; 5():11944. PubMed ID: 26178180
[TBL] [Abstract][Full Text] [Related]
27. COPI coatomer complex proteins facilitate the translocation of anthrax lethal factor across vesicular membranes in vitro.
Tamayo AG; Bharti A; Trujillo C; Harrison R; Murphy JR
Proc Natl Acad Sci U S A; 2008 Apr; 105(13):5254-9. PubMed ID: 18356299
[TBL] [Abstract][Full Text] [Related]
28. Structural determinants for the binding of anthrax lethal factor to oligomeric protective antigen.
Melnyk RA; Hewitt KM; Lacy DB; Lin HC; Gessner CR; Li S; Woods VL; Collier RJ
J Biol Chem; 2006 Jan; 281(3):1630-5. PubMed ID: 16293620
[TBL] [Abstract][Full Text] [Related]
29. Anthrax toxin: receptor binding, internalization, pore formation, and translocation.
Young JA; Collier RJ
Annu Rev Biochem; 2007; 76():243-65. PubMed ID: 17335404
[TBL] [Abstract][Full Text] [Related]
30. LRP5 and LRP6 are not required for protective antigen-mediated internalization or lethality of anthrax lethal toxin.
Young JJ; Bromberg-White JL; Zylstra C; Church JT; Boguslawski E; Resau JH; Williams BO; Duesbery NS
PLoS Pathog; 2007 Mar; 3(3):e27. PubMed ID: 17335347
[TBL] [Abstract][Full Text] [Related]
31. Anthrax lethal factor inhibitors as potential countermeasure of the infection.
Kumar BV; Malik S; Grandhi P; Dayam R; Sarma JA
Curr Top Med Chem; 2014; 14(17):1977-89. PubMed ID: 25262802
[TBL] [Abstract][Full Text] [Related]
32. The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor.
Singh Y; Klimpel KR; Arora N; Sharma M; Leppla SH
J Biol Chem; 1994 Nov; 269(46):29039-46. PubMed ID: 7961869
[TBL] [Abstract][Full Text] [Related]
33. Cell entry and cAMP imaging of anthrax edema toxin.
Dal Molin F; Tonello F; Ladant D; Zornetta I; Zamparo I; Di Benedetto G; Zaccolo M; Montecucco C
EMBO J; 2006 Nov; 25(22):5405-13. PubMed ID: 17082768
[TBL] [Abstract][Full Text] [Related]
34. Internalization of a Bacillus anthracis protective antigen-c-Myc fusion protein mediated by cell surface anti-c-Myc antibodies.
Varughese M; Chi A; Teixeira AV; Nicholls PJ; Keith JM; Leppla SH
Mol Med; 1998 Feb; 4(2):87-95. PubMed ID: 9508786
[TBL] [Abstract][Full Text] [Related]
35. The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen.
Mogridge J; Cunningham K; Lacy DB; Mourez M; Collier RJ
Proc Natl Acad Sci U S A; 2002 May; 99(10):7045-8. PubMed ID: 11997437
[TBL] [Abstract][Full Text] [Related]
36. Cross-linked forms of the isolated N-terminal domain of the lethal factor are potent inhibitors of anthrax toxin.
Juris SJ; Melnyk RA; Bolcome RE; Chan J; Collier RJ
Infect Immun; 2007 Oct; 75(10):5052-8. PubMed ID: 17635861
[TBL] [Abstract][Full Text] [Related]
37. Trp 346 and Leu 352 residues in protective antigen are required for the expression of anthrax lethal toxin activity.
Batra S; Gupta P; Chauhan V; Singh A; Bhatnagar R
Biochem Biophys Res Commun; 2001 Feb; 281(1):186-92. PubMed ID: 11178978
[TBL] [Abstract][Full Text] [Related]
38. Development of a cell-based fluorescence resonance energy transfer reporter for Bacillus anthracis lethal factor protease.
Kimura RH; Steenblock ER; Camarero JA
Anal Biochem; 2007 Oct; 369(1):60-70. PubMed ID: 17586456
[TBL] [Abstract][Full Text] [Related]
39. Fusions of anthrax toxin lethal factor with shiga toxin and diphtheria toxin enzymatic domains are toxic to mammalian cells.
Arora N; Leppla SH
Infect Immun; 1994 Nov; 62(11):4955-61. PubMed ID: 7927776
[TBL] [Abstract][Full Text] [Related]
40. Protein translocation through the anthrax toxin transmembrane pore is driven by a proton gradient.
Krantz BA; Finkelstein A; Collier RJ
J Mol Biol; 2006 Feb; 355(5):968-79. PubMed ID: 16343527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
